Gennex Laboratories Ltd. (GENNE): Gennex Laboratories Share Price Rises 8.24% Today to Rs 10.90

Published: 16 September 2026 at 3:18:41 PM IST

Gennex Laboratories Share Price moved to Rs 10.90 today, up 8.24% from the previous close, with market capitalisation at Rs 268.21 crore. The stock’s share price rise came in a session where the day high matched the close, but the supplied data does not establish a company-specific catalyst. For readers tracking Gennex Laboratories Share Price Today, the move is relevant because it changed the day’s price range, lifted the stock into the Stocks in News conversation and brought fresh attention to its valuation and sector context. Univest is covering the move as a factual stock update, and the numbers below show what changed, what the company is worth on the market, and how Gennex Laboratories compares with healthcare peers on reported fundamentals.

Gennex Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 10.9
Previous Close	Rs 10.07
Today's Move	Rs 0.83 (+8.24%)
Open	Rs 10.39
High	Rs 10.9
Low	Rs 10.01
Turnover	Rs 0.4 crore
Market Capitalisation	Rs 268.21 crore
Market Cap Category	Micro Cap

Gennex Laboratories Ltd. (GENNE) rose to Rs 10.9 from the previous close of Rs 10.07, a move of Rs 0.83 or 8.24%. The stock opened at Rs 10.39, reached a high of Rs 10.9, recorded a low of Rs 10.01.

Gennex Laboratories Share Price Today closed at Rs 10.90, compared with the previous close of Rs 10.07, a gain of Rs 0.83 or 8.24%. The stock opened at Rs 10.39, touched a low of Rs 10.01 and reached a high of Rs 10.90, which also became the closing price. Turnover stood at Rs 0.4 crore. The supplied data confirms a same-day price rise, but it does not establish a company-specific trigger. For investors following Gennex Laboratories Stock News, the key fact is the exact move and the trading range rather than a speculative reason. Univest tracks such price events because they often reshape how a stock appears on Share Market Today screens and in Top Gainers Today lists.

Gennex Laboratories Ltd. (GENNE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 268.21 crore
P/E Ratio	12.61x
P/B Ratio	1.08x
ROE	10.49%
ROCE	12.49%
EPS	Rs 0.8
Book Value Per Share	Rs 9.35
Dividend Yield	0%

Gennex Laboratories Ltd. (GENNE) fundamental metrics show P/E 12.61x, P/B 1.08x, ROE 10.49%, ROCE 12.49%. These figures provide context only and are not a buy or sell signal.

Gennex Laboratories Ltd. has a market capitalisation of Rs 268.21 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 12.61x, P/B at 1.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.49% and ROCE of 12.49%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.8, book value per share of Rs 9.35, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.74x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	12.61x
Benchmark Median P/E	31.74x
Benchmark Average P/E	47.98x
Benchmark P/E Range	3.29x to 683.37x
Company P/B Ratio	1.08x
Benchmark Median P/B	3.02x
Company ROE	10.49%
Benchmark Median ROE	11.78%
Company ROCE	12.49%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 268.21 crore
Benchmark Median Market Cap	Rs 750.5 crore

Gennex Laboratories Ltd. (GENNE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Gennex Laboratories Ltd. (GENNE) has a P/E ratio of 12.61x, which is below the benchmark median of 31.74x, a difference of -60.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gennex Laboratories Ltd. (GENNE) has a ROE of 10.49%, which is below the benchmark median of 11.78%, a difference of -10.95%. Gennex Laboratories Ltd. (GENNE) has a ROCE of 12.49%, which is below the benchmark median of 13.65%, a difference of -8.5%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,41,957.5	36.4	5.09	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,47,576	83.41	13.81	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,233.01	84.58	20.55	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,670.55	24.29	4.07	19.69	21.39
Cipla Ltd.	CIPLA	1,10,272.68	32.62	3.13	11.83	16

Gennex Laboratories Ltd. (GENNE) has a P/E ratio of 12.61x compared with the displayed peer median of 36.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.49% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 12.49% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gennex Laboratories Ltd. (GENNE) has a market capitalisation of Rs 268.21 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Gennex Laboratories

• Gennex Laboratories Share Price rose 8.24% today to Rs 10.90 after closing above the previous close of Rs 10.07.
• The day range was Rs 10.01 to Rs 10.90, and the stock ended at the day high.
• Turnover stood at Rs 0.4 crore in today’s session.
• Market capitalisation is Rs 268.21 crore, with P/E at 12.61 and P/B at 1.08.
• ROE is 10.49% and ROCE is 12.49%, both below the same-industry medians supplied in the benchmark.

About Gennex Laboratories

Gennex Laboratories Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied classification, the company sits within a broad pharma universe that includes large listed manufacturers and more specialised names. The article data does not provide a product or segment breakdown, so the business profile should be read conservatively through its sector label, valuation ratios and market capitalisation. For investors tracking Gennex Laboratories Share Price, the important company context is that it is a listed pharmaceutical player with reported earnings per share of Rs 0.8 and book value per share of Rs 9.35. That combination places the stock in a lower-market-cap part of the healthcare landscape, where changes in Gennex Laboratories Stock News are often assessed through the company’s numbers, the same-industry benchmark and peer valuation comparison. Univest presents this as a factual Company Overview rather than a forecast.

Track Gennex Laboratories Share Price on Univest

Use Gennex Laboratories Ltd. (GENNE) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Frequently Asked Questions

Why is Gennex Laboratories Share Price rising today?

Ans. Gennex Laboratories Share Price rose 8.24% to Rs 10.90 today, but the supplied data does not establish a company-specific catalyst. The session’s open, low, high, close and turnover confirm the price move.

What is Gennex Laboratories Share Price today?

Ans. Gennex Laboratories Share Price today is Rs 10.90. It is up Rs 0.83, or 8.24%, from the previous close of Rs 10.07, with the closing price equal to the day high.

What is the market capitalisation of Gennex Laboratories?

Ans. Gennex Laboratories has a market capitalisation of Rs 268.21 crore. That is below the same-industry median of Rs 750.5 crore and below the average of Rs 14,144.11 crore across 200 companies.

How is Gennex Laboratories valued on P/E and P/B?

Ans. Gennex Laboratories trades at a P/E of 12.61 and a P/B of 1.08. Both are below the same-industry medians of 31.74 and 3.02, respectively, in the supplied benchmark. The company trades at a P/E ratio of 12.61x.

What do ROE and ROCE show for Gennex Laboratories?

Ans. Gennex Laboratories reports ROE of 10.49% and ROCE of 12.49%. Both are slightly below the benchmark medians in the same-industry comparison, which helps frame the stock’s reported profitability. ROE stands at 10.49%.

What are the EPS and book value for Gennex Laboratories?

Ans. Gennex Laboratories reports EPS of Rs 0.8 and book value of Rs 9.35. EPS reflects earnings attributable to each share, while book value per share reflects the accounting net worth behind each share.

Does Gennex Laboratories pay a dividend?

Ans. The supplied dividend yield for Gennex Laboratories is 0. That means the article can only state the reported yield, not any future payout expectation. Investors usually read this alongside earnings and book value.

How does Gennex Laboratories compare with healthcare peers?

Ans. Gennex Laboratories is smaller in market capitalisation than the supplied peers and trades at lower P/E and P/B multiples. Its ROE and ROCE are also below most peer figures, based on the displayed data.